Celldex Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Celldex Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Celldex Therapeutics Inc.
Rating: 1.36066675
Author: Trendlyne DVM scores

about

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, a...

29.11 -1.03 (-3.42%)

51.30% Gain from 52W Low

468.8K

XNAS Volume

XNAS 02 Jun, 2026 3:25 PM (EDT)

Board Meeting

The next board meeting for Celldex Therapeutics Inc is on 05 Jun 2026 for the purpose of Celldex Therapeutics Inc Annual General Meeting for 2026 See details

Not Eligible

Expensive Valuation

3.7 / 100

Technically Neutral

50.8 / 100

1Yr Price target upside is 101%

14 analysts

Celldex Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celldex Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, a...

51.30% Gain from 52W Low

SWOT Analysis

Celldex Therapeutics Inc Live Price Chart